Longitudinal Insights Into Childhood Onset Facioscapulohumeral Dystrophy: A 5-Year Natural History Study

Jildou N Dijkstra1, Helena T M Boon1, Anne Koekkoek1

  • 1From the Department of Neurology (J.N.D., H.T.M.B., N.V.A., B.G.M.V.E., N.C.V.); Department of Pediatric Neurology (J.N.D., H.T.M.B., A.K., C.E.E.), Donders Institute for Brain, Cognition and Behaviour, Amalia Children's Hospital, Radboud University Medical Centre, Nijmegen, The Netherlands; Department of Neurology (R.J.M.G.), Jönköping, and Department of Biomedical and Clinical Sciences, Linköping University, Sweden; Department of Rehabilitation (M.M.P., S.L.S.H.), Donders Institute for Brain, Cognition and Behaviour, Amalia Children's Hospital; and Department of Neurology (N.V.A.), Clinical Neuromuscular Imaging Group, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.

Neurology
|December 17, 2024
PubMed

Insights

Childhood facioscapulohumeral dystrophy (FSHD) shows variable progression, often unnoticed by patients. Sensitive outcome measures like FSHD-CS and muscle ultrasonography are key for tracking disease in pediatric trials.

Area of Science:

  • Neurology
  • Genetics
  • Pediatrics

Background:

  • Facioscapulohumeral dystrophy (FSHD) is an inherited muscle disorder with a significant proportion of childhood-onset cases.
  • Understanding the natural history and identifying reliable outcome measures for pediatric FSHD is critical for effective clinical management and therapeutic development.

Purpose of the Study:

  • To investigate the natural history of childhood-onset facioscapulohumeral dystrophy (FSHD) over a 5-year period.
  • To identify sensitive clinical and functional outcome measures for pediatric FSHD.

Main Methods:

  • A prospective, nationwide cohort study (iFocus) involving 20 patients with childhood-onset FSHD.
  • Regular assessments included manual muscle testing, functional muscle tests, FSHD clinical score (FSHD-CS), FSHD clinical severity scale (FSHD-CSS), and muscle ultrasonography (MUS) over 5 years.

Main Results:

  • Eighteen patients completed the 5-year follow-up, revealing variable disease progression with a mean FSHD-CS increase of 1.6.
  • Despite objective progression, 89% of participants did not perceive any change in their condition.
  • The most sensitive outcome measures identified were FSHD-CS (SRM 1.07), FSHD-CSS (SRM 0.92), and MUS (SRM 0.68).

Conclusions:

  • Disease progression in childhood FSHD is variable and often clinically unperceived, emphasizing the need for sensitive outcome measures.
  • Quality of life improved, and fatigue decreased over the study period.
  • Future pediatric FSHD studies should utilize larger cohorts, incorporate reachable workspace assessments, muscle ultrasonography, and the FSHD functional composite outcome measure (FSHD-COM).
Abstract

Related Concept Videos

Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Changes in the Appendicular Skeleton with Age01:09

Changes in the Appendicular Skeleton with Age

The upper and lower limb initially develops as a small bulge called a limb bud, which appears on the lateral side of the early embryo. The upper limb bud appears near the end of the fourth week of development, with the lower limb bud appearing shortly after.
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
Longitudinal Studies01:26

Longitudinal Studies

Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...